Compare Moderna, Inc. (MRNA) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Taskus Inc — how do they compare? Moderna, Inc. trades at $59.38 (market cap $23.60B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Moderna, Inc. is far larger — about 44.4× Taskus Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | TASK | |
|---|---|---|
Market Cap | $23.60B | $532.07M |
Sector | Health | Technology |
52-Week High | $81.80 | $18.21 |
52-Week Low | $22.36 | $4.57 |
Enterprise Value | $19.70B | $927.77M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
